logo

For the Inventor, By the Inventor

Evansville, IN, United States of America

Tellis A Martin

USPTO Granted Patents = 11

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal11 out of 142 
 
Mead Johnson & Company
 patents

Years Active: 1976-1986

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4617291 - Angiotensin-converting enzyme inhibiting dipeptide derivatives (1986-10-14),
2. 4600758 - Isoindole derivatives (1986-07-15),
3. 4505911 - Isoindole diuretic derivatives, compositions and use (1985-03-19),
4. 4495194 - Antihypertensive isoindole derivatives (1985-01-22),
5. 4178301 - Benzoic acid derivatives (1979-12-11),
6. 4132803 - Mercaptoacylamidobenzoylglycine mucolytic process and compositions (1979-01-02),
7. 4132802 - Benzoic acid derivative and benzenesulfonic acid mucolytic process (1979-01-02),
8. 4096277 - Mucolytic mercaptoacylamidobenzamides and process of using same (1978-06-20),
9. 4093739 - Mercaptoacylamidobenzoyl glycine and mucolytic process (1978-06-06),
10. 4005222 - Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds (1977-01-25),
11. 3965167 - Crystalline ammonium N-acetyl-L-cysteinate and mucolytic process (1976-06-22),

Title: The Innovative Contributions of Tellis A Martin

Introduction: Tellis A Martin is a prominent inventor based in Evansville, Indiana, known for his significant contributions to medical science through his innovative patents. With a total of 11 patents under his name, Martin is recognized for his dedication to developing solutions that address various health issues, particularly hypertension.

Latest Patents: Among his latest contributions, Martin developed angiotensin-converting enzyme inhibiting dipeptide derivatives. These dipeptides possess a unique chemical structure that allows them to act as inhibitors of angiotensin-converting enzyme, making them valuable for treating hypertension in mammals. Another noteworthy patent includes isoindole derivatives, which are novel phthalimide intermediates that yield 5-sulfamoyl-6-halo-3-oxoisoindole compounds. These compounds are known for their diuretic and antihypertensive properties, showcasing Martin's focus on improving cardiovascular health.

Career Highlights: Martin has built a remarkable career at Mead Johnson & Company, where he has spearheaded numerous research initiatives aimed at developing innovative healthcare solutions. His expertise and persistent efforts have led to advancements in pharmaceutical formulations that contribute to better health outcomes for patients.

Collaborations: Throughout his career, Tellis A Martin has collaborated with notable colleagues, including William T Comer and Terence M Dolak. These partnerships have fostered an environment of creativity and innovation, enabling the development of groundbreaking products and therapies.

Conclusion: Tellis A Martin's impact on the field of medical science through his patents is significant. His work continues to help improve health and quality of life for many individuals, reinforcing the importance of innovation in addressing critical health challenges. His contributions serve as an inspiration to aspiring inventors and researchers dedicated to making a difference through their work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…